| Therapeutic basis of glycyrrhizin on chronic hepatitis B H Sato, W Goto, J Yamamura, M Kurokawa, S Kageyama, T Takahara, ... Antiviral research 30 (2-3), 171-177, 1996 | 294 | 1996 |
| Prophylactic treatment of cytomegalovirus infection with traditional herbs TA Yukawa, M Kurokawa, H Sato, Y Yoshida, S Kageyama, T Hasegawa, ... Antiviral research 32 (2), 63-70, 1996 | 154 | 1996 |
| A natural inter‐genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines S Kageyama, DM Agdamag, ET Alesna, PS Leaño, AML Heredia, ... Journal of medical virology 78 (11), 1423-1428, 2006 | 125 | 2006 |
| Targeted therapy of human immunodeficiency virus‐related disease H Mitsuya, R Yarchoan, S Kageyama, S Broder The FASEB journal 5 (10), 2369-2381, 1991 | 125 | 1991 |
| In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine S Kageyama, T Mimoto, Y Murakawa, M Nomizu, H Ford Jr, T Shirasaka, ... Antimicrobial agents and chemotherapy 37 (4), 810-817, 1993 | 118 | 1993 |
| Plasma HIV-1 viremia in HIV-1 infected individuals assessed by polymerase chain reaction S AOKI-SEI, R YARCHOAN, S KAGEYAMA, DT HOEKZEMA, JM PLUDA, ... AIDS research and human retroviruses 8 (7), 1263-1270, 1992 | 94 | 1992 |
| Extract of Prunella Vulgaris Spikes Inhibits HIV Replication at Reverse Transcription in vitro and can Be Absorbed from Intestine in vivo S Kageyama, M Kurokawa, K Shiraki Antiviral Chemistry and Chemotherapy 11 (2), 157-164, 2000 | 75 | 2000 |
| Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2', 3'-dideoxyadenosine and 2', 3'-dideoxyinosine. NR Hartman, GS Ahluwalia, DA Cooney, H Mitsuya, S Kageyama, ... Molecular pharmacology 40 (1), 118-124, 1991 | 75 | 1991 |
| Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia AA Prasetyo, P Dirgahayu, Y Sari, H Hudiyono, S Kageyama The Journal of Infection in Developing Countries 7 (06), 453-467, 2013 | 73 | 2013 |
| Protein binding of human immunodeficiency virus protease inhibitor KNI-272 and alteration of its in vitro antiretroviral activity in the presence of high concentrations of proteins S Kageyama, BD Anderson, BL Hoesterey, H Hayashi, Y Kiso, KP Flora, ... Antimicrobial agents and chemotherapy 38 (5), 1107-1111, 1994 | 71 | 1994 |
| In vitro inhibition of human immunodeficiency virus (HIV) type 1 replication by C2 symmetry-based HIV protease inhibitors as single agents or in combinations S Kageyama, JN Weinstein, T Shirasaka, DJ Kempf, DW Norbeck, ... Antimicrobial agents and chemotherapy 36 (5), 926-933, 1992 | 65 | 1992 |
| RANTES –28G Delays and DC-SIGN – 139C Enhances AIDS Progression in HIV Type 1-Infected Japanese Hemophiliacs Y Koizumi, S Kageyama, Y Fujiyama, M Miyashita, R Lwembe, K Ogino, ... AIDS research and human retroviruses 23 (5), 713-719, 2007 | 58 | 2007 |
| Impact of blood pressure control on thromboembolism and major hemorrhage in patients with nonvalvular atrial fibrillation: a subanalysis of the J‐RHYTHM Registry E Kodani, H Atarashi, H Inoue, K Okumura, T Yamashita, T Otsuka, ... Journal of the American Heart Association 5 (9), e004075, 2016 | 57 | 2016 |
| Genetic diversity of HIV type 1 in rural eastern Cameroon N Ndembi, J Takehisa, L Zekeng, E Kobayashi, C Ngansop, EM Songok, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 37 (5), 1641-1650, 2004 | 55 | 2004 |
| Morphological subtyping of acute myeloid leukemia with maturation (AML-M2): homogeneous pink-colored cytoplasm of mature neutrophils is most characteristic of AML-M2 with t (8; 21) H Nakamura, K Kuriyama, N Sadamori, M Mine, T Itoyama, I Sasagawa, ... Leukemia 11 (5), 651-655, 1997 | 54 | 1997 |
| Rapid detection of human immunodeficiency virus type 1 group M by a reverse transcription-loop-mediated isothermal amplification assay N Hosaka, N Ndembi, A Ishizaki, S Kageyama, K Numazaki, H Ichimura Journal of virological methods 157 (2), 195-199, 2009 | 51 | 2009 |
| Men having sex with men in Surakarta, Indonesia: demographics, behavioral characteristics and prevalence of blood borne pathogens AA Prasetyo, ER Ariapramuda, E Al Kindi, P Dirgahayu, Y Sari, ... Southeast Asian Journal of Tropical Medicine and Public Health 45 (5), 1032, 2014 | 50 | 2014 |
| Emergence of resistance to acyclovir and penciclovir in varicella-zoster virus and genetic analysis of acyclovir-resistant variants M Ida, S Kageyama, H Sato, T Kamiyama, J Yamamura, M Kurokawa, ... Antiviral research 40 (3), 155-166, 1999 | 48 | 1999 |
| Profile of HIV type 1 infection and genotypic resistance mutations to antiretroviral drugs in treatment-naive HIV type 1-infected individuals in Hai Phong, Viet Nam A Ishizaki, NH Cuong, PV Thuc, NV Trung, K Saijoh, S Kageyama, ... AIDS research and human retroviruses 25 (2), 175-182, 2009 | 47 | 2009 |
| Anti‐retroviral drug resistance‐associated mutations among non‐subtype B HIV‐1‐infected Kenyan children with treatment failure R Lwembe, W Ochieng, A Panikulam, CO Mongoina, T Palakudy, ... Journal of medical virology 79 (7), 865-872, 2007 | 44 | 2007 |
